RxDoctor Payments Data

Charity Snyder, PA

Medical · Milford, NYNPI 1972933661

Payments from drug & device makers

$501in general payments, 2019–2025

Across 38 payments — averaging $13.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$186
  • Novartis$68
  • Galderma Laboratories, L.p.$53
  • UCB, Inc.$35
  • Journey Medical Corporation$34
  • Regeneron Healthcare Solutions, Inc.$32
  • plus $93 from 5 others

What the payments were for

  • Food & beverage$501100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$501 in reported general payments places this provider in the 55th percentile of 2,395 medical providers in New York.

See all medical providers in New York

Medicare billing

Part B allowed, 2024
$114,103
Medicare patients
741
Services billed
3,586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab12$271,967
Humira PenAdalimumab25$170,803
Humira(Cf) PenAdalimumab12$148,532
Dupixent PenDupilumab34$142,358
OtezlaApremilast17$83,115
Dupixent SyringeDupilumab14$57,042
Fluorouracil77$5,537
Clobetasol Propionate78$2,675
Tacrolimus16$2,609
Metronidazole51$2,403
Calcipotriene11$2,064
Ketoconazole93$1,612
Triamcinolone Acetonide111$1,370
Halobetasol Propionate15$1,312
Clindamycin Phosphate20$1,259

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$186$271,96712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,395 medical providers in New York.

Other medical in Milford

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →